Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V3DQ
|
||||
Former ID |
DIB018326
|
||||
Drug Name |
[3H]LXA4
|
||||
Synonyms |
[3H]-LXA4
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540356] | ||
Formula |
C20H32O5
|
||||
InChI |
InChI=1S/C20H34O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h5,7,9-10,13-14,17-19,21-23H,2-4,6,8,11-12,15-16H2,1H3,(H,24,25)/b7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1/i4T,6T
|
||||
InChIKey |
BIAXEQCLMUBCBP-BASHJZMHSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | FMLP-related receptor I | Target Info | Agonist | [526742] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.